Middle East: Medicaments Containing Hormones Market 2024

Medicaments Containing Hormones Market Size in the Middle East

The Middle Eastern medicaments containing hormones market rose notably to $X in 2022, picking up by X% against the previous year. In general, consumption recorded a remarkable increase. The level of consumption peaked at $X in 2017; afterwards, it flattened through to 2022.

Medicaments Containing Hormones Production in the Middle East

In value terms, medicaments containing hormones production reached $X in 2022 estimated in export price. In general, production, however, saw strong growth. The growth pace was the most rapid in 2014 when the production volume increased by X%. The level of production peaked at $X in 2020; however, from 2021 to 2022, production remained at a lower figure.

Medicaments Containing Hormones Exports

Exports in the Middle East

In 2022, the amount of medicaments containing hormones but not antibiotics exported in the Middle East fell remarkably to X tons, with a decrease of X% compared with 2021 figures. In general, exports saw a noticeable curtailment. The pace of growth appeared the most rapid in 2018 with an increase of X% against the previous year. Over the period under review, the exports hit record highs at X tons in 2012; however, from 2013 to 2022, the exports failed to regain momentum.

In value terms, medicaments containing hormones exports declined to $X in 2022. Overall, exports saw a abrupt contraction. The most prominent rate of growth was recorded in 2018 when exports increased by X% against the previous year. Over the period under review, the exports reached the peak figure at $X in 2012; however, from 2013 to 2022, the exports remained at a lower figure.

Exports by Country

Kuwait dominates exports structure, reaching X tons, which was approx. X% of total exports in 2022. Saudi Arabia (X tons) held a relatively small share of total exports.

Kuwait was also the fastest-growing in terms of the medicaments containing hormones but not antibiotics exports, with a CAGR of X% from 2012 to 2022. Saudi Arabia (X%) illustrated a downward trend over the same period. From 2012 to 2022, the share of Kuwait increased by X percentage points, while the shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, Kuwait ($X) remains the largest medicaments containing hormones supplier in the Middle East, comprising X% of total exports. The second position in the ranking was taken by Saudi Arabia ($X), with a X% share of total exports.

From 2012 to 2022, the average annual rate of growth in terms of value in Kuwait amounted to X%.

Export Prices by Country

The export price in the Middle East stood at $X per ton in 2022, growing by X% against the previous year. In general, the export price, however, saw a perceptible descent. The most prominent rate of growth was recorded in 2015 an increase of X%. The level of export peaked at $X per ton in 2016; however, from 2017 to 2022, the export prices remained at a lower figure.

Prices varied noticeably by country of origin: amid the top suppliers, the country with the highest price was Saudi Arabia ($X per ton), while Kuwait totaled $X per ton.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Kuwait (X%).

Medicaments Containing Hormones Imports

Imports in the Middle East

After four years of decline, supplies from abroad of medicaments containing hormones but not antibiotics increased by X% to X tons in 2022. Overall, imports, however, saw a perceptible slump. The volume of import peaked at X tons in 2017; however, from 2018 to 2022, imports failed to regain momentum.

In value terms, medicaments containing hormones imports skyrocketed to $X in 2022. Over the period under review, imports, however, recorded a abrupt downturn. The pace of growth was the most pronounced in 2014 with an increase of X% against the previous year. The level of import peaked at $X in 2015; however, from 2016 to 2022, imports remained at a lower figure.

Imports by Country

The United Arab Emirates represented the main importer of medicaments containing hormones but not antibiotics in the Middle East, with the volume of imports accounting for X tons, which was near X% of total imports in 2022. Qatar (X tons) held a X% share (based on physical terms) of total imports, which put it in second place, followed by Saudi Arabia (X%), Oman (X%) and Bahrain (X%). The following importers - Iraq (X tons) and Yemen (X tons) - each accounted for a X% share of total imports.

From 2012 to 2022, the biggest increases were recorded for the United Arab Emirates (with a CAGR of X%), while purchases for the other leaders experienced more modest paces of growth.

In value terms, the United Arab Emirates ($X), Saudi Arabia ($X) and Qatar ($X) appeared to be the countries with the highest levels of imports in 2022, with a combined X% share of total imports.

In terms of the main importing countries, the United Arab Emirates, with a CAGR of X%, saw the highest rates of growth with regard to the value of imports, over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

The import price in the Middle East stood at $X per ton in 2022, with a decrease of X% against the previous year. In general, the import price saw a deep contraction. The pace of growth appeared the most rapid in 2014 an increase of X%. As a result, import price attained the peak level of $X per ton. From 2015 to 2022, the import prices failed to regain momentum.

Prices varied noticeably by country of destination: amid the top importers, the country with the highest price was Iraq ($X per ton), while Bahrain ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Yemen (X%), while the other leaders experienced mixed trends in the import price figures.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :